{"id":"W2034666734","doi":"10.1016/s0093-7754(01)90261-1","title":"Zoledronic acid in the treatment of hypercalcemia of malignancy: Results of the international clinical development program","year":2001,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hamilton Regional Laboratory Medicine Program","funders":"","keywords":"Zoledronic acid; Medicine; Bisphosphonate; Internal medicine; Clinical trial; Urology; Refractory (planetary science); Randomized controlled trial; Malignancy; Gastroenterology; Surgery; Osteoporosis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009455394,0.0002513941,0.001990397,0.0001885851,0.00001581591,0.000001168974,0.0003579165,0.0005181515,0.00001860654],"category_scores_gemma":[0.0002196999,0.0001258409,0.0003769817,0.0004370547,0.0002407763,0.00001052162,0.00006421941,0.0003515327,0.000005263978],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001065057,"about_ca_system_score_gemma":0.002984845,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001277562,"about_ca_topic_score_gemma":0.0006877015,"domain_scores_codex":[0.9963697,0.0004673961,0.002266622,0.0003175779,0.0002992399,0.0002794453],"domain_scores_gemma":[0.9976369,0.0007401212,0.001002284,0.0004954693,0.00007021509,0.00005508167],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004062597,0.006808946,0.0102874,0.001379784,0.0002014214,0.000130002,0.0006384403,1.397093e-7,2.305476e-7,0.00001642908,0.0002527765,0.9798782],"study_design_scores_gemma":[0.004423124,0.003852179,0.006687091,0.01083137,0.000395735,0.0001929436,0.00007505776,0.000001524727,0.00001766152,0.0000174881,0.9734315,0.00007436475],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0199547,0.9710477,1.558482e-7,0.0004391855,0.0005468467,0.003121925,0.00004308132,0.00000615725,0.004840232],"genre_scores_gemma":[0.003313473,0.9941455,0.001330441,0.00006226983,0.00004604084,0.0005251049,0.0001299297,0.00001723371,0.0004299971],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9798038,"threshold_uncertainty_score":0.5294986,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.128744099947459,"score_gpt":0.4871120132950055,"score_spread":0.3583679133475465,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}